New Cancer Drugs Are Revolutionary. Why Don’t More Patients Get Them?
Targeted gene therapies are highly effective at stopping cancers, but the very abundance of the treatments, plus cost and sluggish change, are hindering access.
Read the full story at NYT Science ↗
ImpactNotable 35/100
Why it mattersRule-based estimate: no strong signals; trust 9/10.
RegionsUnited States
Published4 h ago (Wed, 30 Sep 2026 09:01:30 GMT)
RetrievedWed, 30 Sep 2026 10:00:56 GMT via rss
ClassifiedWed, 30 Sep 2026 10:01:14 GMT by heuristic
AuthorGina Kolata